Catalyst Wire Dossier Catalyst Wire Dossier

TRI-LEGEST FE 28 DAY

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TRI-LEGEST FE 28 DAY, covering 2007-10-26 to 2025-06-18. Get the full timeline:

Most recent: FDA Approved: TRI-LEGEST FE 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing